Centrum Medyczne BIOTAMED
- Address
- ul. Wincentego Pola 4a, 32-020 Wieliczka, Poland
Otorhinolaryngologic Diseases and Respiratory Tract Diseases
At Centrum Medyczne BIOTAMED in Wieliczka, clinical research is focused on chronic rhinosinusitis and related upper airway conditions. The studies are designed to assess new treatment options and better understand how these diseases affect patients’ daily lives.
- Research on Chronic Rhinosinusitis With Nasal Polyps is evaluating whether a new therapy can reduce nasal blockage and improve polyp-related symptoms.
- Work in Chronic Rhinosinusitis without Nasal Polyps is testing whether an investigational treatment can ease nasal symptoms and improve overall comfort.
- Some research also explores patient-reported experiences to better capture symptom changes and treatment satisfaction during care.
This site is contributing to studies that aim to improve treatment effectiveness and expand understanding of sinus disease in adults.
Chronic Rhinosinusitis With Nasal Polyps
Clinical trials in this area are centered on nasal polyps and persistent sinus inflammation, with the goal of finding therapies that can relieve congestion and improve endoscopic findings. The research also includes patient-centered assessment of how symptoms change over time.
- Testing a potential new treatment to reduce nasal congestion and polyp severity.
- Studying how adults with CRSwNP describe symptom burden, improvement, and treatment experience.
- Evaluating whether current therapy combinations can better control chronic inflammation in the nose and sinuses.
These trials are helping clarify which approaches may offer more meaningful relief for people living with long-term rhinosinusitis.
Chronic Rhinosinusitis without Nasal Polyps
Research in CRSsNP at this site is aimed at improving nasal symptom control in patients who have ongoing sinus disease but no visible polyps. The main purpose is to evaluate whether an investigational therapy can provide better symptom relief than standard care alone.
- Assessing treatment effectiveness for persistent sinus inflammation and nasal discomfort.
- Measuring improvement in day-to-day symptoms that affect breathing and quality of life.
- Supporting a better understanding of how chronic rhinosinusitis behaves in adults without polyps.
At Centrum Medyczne BIOTAMED, this work contributes to broader efforts to refine care for upper respiratory tract disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne BIOTAMED
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps – The BiRCh Study | Insmed Inc. | Phase II | Not Recruiting | May 2024 | Oct 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BRENSOCATIB | 1 | Unknown | 2024-05-23 | 2024-05-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.